Posted on March 29, 2010 by BioJobBlogger

Another Pharma List: Does Size Really Matter?

Ed Silverman who runs the outstanding Pharmalot Blog, today posted a 2009 list of the world’s top 20 pharmaceutical companies. The list was compiled by IMS Health and placement was based on revenues generated from 2009 prescription drug sales.  The numbers in parentheses represent the percent change from the previous year.

FYI, the Pfizer-Wyeth and Merck-Schering Plough acquisitions weren’t included whereas the Roche-Genentech acquisition was. Also, it is interesting to note that Teva, the world’s largest generic drug manufacturer came in at number 11and exhibited the greatest increase in sales in 2009. Expect the Israeli drug giant to move into the top ten next year as generic drug sales continue to out pace those of branded products.

  1. Pfizer - $41.7 billion - (0.8)
  2. Novartis - $36.7 billion - 7.0
  3. Sanofi-Aventis - $35.1 billion - (3.3)
  4. GlaxoSmithKline - $34.3 billion - (3.4)
  5. AstraZeneca - $33.2 billion - (7.8)
  6. Roche - $31.3 billion - (8.6)
  7. Johnson & Johnson - $26.9 billion - (6.6)
  8. Merck - $25.0 billion - (4.1)
  9. Eli Lilly - $19.6 billion - (8.3)
  10. Abbott - $19.4 billion - (5.5)
  11. Teva - $15.7 billion - (12.3)
  12. Bayer - $15.4 billion - (3.9)
  13. Wyeth - $14.8 billion - (2.3)
  14. Amgen - $14.8 billion - (3.1)
  15. Boehringer - $14.6 billion - (10.4)
  16. Takeda - $14.4 billion - (2.1)
  17. Bristol-Myers - $14.2 billion - (5.8)
  18. Schering-Plough - $13.1 billion - (4.3)
  19. Daiichi Sankyo - $8.5 billion - (3.1)
  20. Novo Nordisk - $8.2 billion (11.6)

Hat tip to Pharmalot

Until next time…

Good Luck and Good Job Hunting!!!!!!!

 

Tags: , , , , , , , , , , ,
Posted on October 15, 2009 by BioJobBlogger

Science Magazine Survey: American Life Sciences Companies are Some of the Best to Work for in the World

An annual survey conducted by Science magazine and the American Association has identified the 2008 top twenty life sciences employers in the world. The rankings were based on a company’s leadership, stability, social responsibility and treatment of its employees. Six of the top 10— Genentech, Gilead Sciences, Genzyme Corp., Schering-Plough Corp., Gilead Sciences are based in the US whereas the remaining four—Boehringer Ingelheim, Roche Pharmaceuticals, EMD Serono, and Millennium are headquartered outside of the US. For the first time, eight of the top 20 are located outside the United States.

In case you were wondering, Genentech was ranked number 1. This is the fifth time out of the past 6 years that the San-Francisco based company made it to the number one slot (it fell to second last year). Another notable is Massachusetts-based Genzyme which made it to the number 3 spot (out of 575 companies) for the second consecutive year. Surprisingly, Monsanto, the company that makes genetically modified seed crops, was number 2—this despite all of the negative press about genetically modified foods. Let see whether or not Genentech can retain its number 1 ranking after the Roche takeover of the company is completed.

Until next time....

Good Luck and Good Job Hunting!!!!!!!

 

Tags: , , , , , , , , , , , , , , , , , ,